O. Zenker

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

John B. Hagan, Mary Beth Fasano, Sheldon Spector et al. · Journal of Clinical Immunology · 2010 · 131 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy

Stephen Jolles, Ewa Bernatowska, Michael Borte et al. · Clinical Immunology · 2011 · 119 citations · Full text

Medicine, Immunology, Pharmacology +13

Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies

Melvin Berger, Mikhail Rojavin, O. Zenker · Clinical Immunology · 2011 · 109 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +11

Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?

Theodora Kanni, O. Zenker, Maria Habel et al. · British Journal of Dermatology · 2018 · 80 citations · Full text

Life Sciences, Immunology, Pathology +15

Efficacy and safety of Privigen^® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase <scp>III</scp> study (the <scp>PRIMA</scp> study)

Jean‐Marc Léger, Jan De Bleecker, Claudia Sommer et al. · Journal of the Peripheral Nervous System · 2013 · 76 citations · Full text

Medicine, Neurology, Pharmacotherapy +12